UniProtKB/Swiss-Prot P41235: Variant p.Val264Met

Hepatocyte nuclear factor 4-alpha
Gene: HNF4A
Feedback?

Variant information Variant position:

264 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Valine (V) to Methionine (M) at position 264 (V264M, p.Val264Met). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

Found in a patient with non-insulin-dependent diabetes mellitus; does not affect activity. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs139779712 [ dbSNP | Ensembl ]

Sequence information Variant position:

264 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

474 The length of the canonical sequence.
Location on the sequence:

LLGNDYIVPRHCPELAEMSR V SIRILDELVLPFQELQIDDN The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         LLGNDYIVPRHCPELAEMSRVSIRILDELVLPFQELQIDDN

Mouse                         LLGNDYIVPRHCPELAEMSRVSIRILDELVLPFQELQIDDN

Rat                           LLGNDYIVPRHCPELAEMSRVSIRILDELVLPFQELQIDDN

Xenopus laevis                LLGNDRLIPRNCPEL-EVGRVAVRILDELVLPFQELQIDDN

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 474	Hepatocyte nuclear factor 4-alpha
Domain	147 – 377	NR LBD
Helix	262 – 271

Literature citations
Studies of the genetic variability of the coding region of the hepatocyte nuclear factor-4alpha in Caucasians with maturity onset NIDDM.
Moeller A.M.; Urhammer S.A.; Dalgaard L.T.; Reneland R.; Berglund L.; Hansen T.; Clausen J.O.; Lithell H.; Pedersen O.;
Diabetologia 40:980-983(1997)
Cited for: VARIANTS ILE-139 AND MET-264; Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q).
Navas M.A.; Munoz-Elias E.J.; Kim J.; Shih D.; Stoffel M.;
Diabetes 48:1459-1465(1999)
Cited for: CHARACTERIZATION OF VARIANT MET-264; CHARACTERIZATION OF VARIANT MODY1 GLN-285;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.